Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy (BLAD-RAD01)
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy: a Prospective Randomized Comparative Phase II Trial
Sponsor: Institut Claudius Regaud
Listed as NCT04428554, this PHASE2 trial focuses on Urothelial Bladder Cancer and remains actively recruiting participants. Sponsored by Institut Claudius Regaud, it has been updated 21 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
21 versions recorded-
Dec 2025 — Present [monthly]
Recruiting PHASE2
-
Oct 2025 — Dec 2025 [monthly]
Recruiting PHASE2
-
Sep 2025 — Oct 2025 [monthly]
Recruiting PHASE2
-
Nov 2024 — Sep 2025 [monthly]
Recruiting PHASE2
-
Sep 2024 — Nov 2024 [monthly]
Recruiting PHASE2
▶ Show 16 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE2
-
Oct 2023 — Mar 2024 [monthly]
Recruiting PHASE2
-
Sep 2023 — Oct 2023 [monthly]
Recruiting PHASE2
-
Aug 2023 — Sep 2023 [monthly]
Recruiting PHASE2
-
Mar 2023 — Aug 2023 [monthly]
Recruiting PHASE2
-
Nov 2022 — Mar 2023 [monthly]
Recruiting PHASE2
-
Jul 2022 — Nov 2022 [monthly]
Recruiting PHASE2
-
Dec 2021 — Jul 2022 [monthly]
Recruiting PHASE2
-
Oct 2021 — Dec 2021 [monthly]
Recruiting PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE2
-
Apr 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
Feb 2021 — Apr 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut Claudius Regaud
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Albi, France , Angers, France , Besançon, France , Bordeaux, France , Brest, France , Caen, France , Clermont-Ferrand, France , Dunkirk, France , Lille, France , Marseille, France and 8 more locations